Immunogenicity 483
Sample ID
None
Response
Negative
Tumor Type
Melanoma
Gene Symbol
TP63
Transcript ID
None
HLA INFO
A*01:03
TCR INFO
No TCR info found!
Full length protein sequence (676 aa)
MNFET
1
SRCAT
6
LQYCP
11
DPYIQ
16
RFVET
21
PAHFS
26
WKESY
31
YRSTM
36
SQSTQ
41
TNEFL
46
SPEVF
51
QHIWD
56
FLEQP
61
ICSVQ
66
PIDLN
71
FVDEP
76
SEDGA
81
TNKIE
86
ISMDC
91
IRMQD
96
SDLSD
101
PMWPQ
106
YTNLG
111
LLNSM
116
DQQIQ
121
NGSSS
126
TSPYN
131
TDHAQ
136
NSVTA
141
PSPYA
146
QPSST
151
FDALS
156
PSPAI
161
PSNTD
166
YPGPH
171
SFDVS
176
FQQSS
181
TAKSA
186
TWTYS
191
TELKK
196
LYCQI
201
AKTCP
206
IQIKV
211
MTPPP
216
QGAVI
221
RAMPV
226
YKKAE
231
HVTEV
236
VKRCP
241
NHELS
246
REFNE
251
GQIAP
256
PSHLI
261
RVEGN
266
SHAQY
271
VEDPI
276
TGRQS
281
VLVPY
286
EPPQV
291
GTEFT
296
TVLYN
301
FMCNS
306
SCVGG
311
MNRRP
316
ILIIV
321
TLETR
326
DGQVL
331
GRRCF
336
EARIC
341
ACPGR
346
DRKAD
351
EDSIR
356
KQQVS
361
DSTKN
366
GDAFR
371
QNTHG
376
IQMTS
381
IKKRR
386
SPDDE
391
LLYLP
396
VRGRE
401
TYEML
406
LKIKE
411
SLELM
416
QYLPQ
421
HTIET
426
YRQQQ
431
QQQHQ
436
HLLQK
441
QTSIQ
446
SPSSY
451
GNSSP
456
PLNKM
461
NSMNK
466
LPSVS
471
QLINP
476
QQRNA
481
LTPTT
486
IPDGM
491
GANIP
496
MMGTH
501
MPMAG
506
DMNGL
511
SPTQA
516
LPPPL
521
SMPST
526
SHCTP
531
PPPYP
536
TDCSI
541
VSFLA
546
RLGCS
551
SCLDY
556
FTTQG
561
LTTIY
566
QIEHY
571
SMDDL
576
ASLKI
581
PEQFR
586
HAIWK
591
GILDH
596
RQLHE
601
FSSPS
606
HLLRT
611
PSSAS
616
TVSVG
621
SSETR
626
GERVI
631
DAVRF
636
TLRQT
641
ISFPP
646
RDEWN
651
DFNFD
656
MDARR
661
NKQQR
666
IKEEG
671
E
676
Mutation Information
DNA mutation:
None
Peptide Range:
447 ~ 470
Mut AA position:
None (None in Wild Type peptide)
Alignment
Wild Type:
"------TSIQSPSSY---------
|||||||.|
Mutant:
HLLQKQTSIQSPSLYGNSSPPLNK"
Nature, 2017
An immunogenic personal neoantigen vaccine for patients with melanomaGene Name (from Reference) TP63
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
peptide
T-cell
Source
PBMCs
APC
Type
autologous APCs
Assay
IFNg ELISPOT assay